TY - JOUR
T1 - Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)
AU - Dong, Yuxiang
AU - Wang, Xiaofang
AU - Kamaraj, Sriraghavan
AU - Bulbule, Vivek J.
AU - Chiu, Francis C.K.
AU - Chollet, Jacques
AU - Dhanasekaran, Manickam
AU - Hein, Christopher D.
AU - Papastogiannidis, Petros
AU - Morizzi, Julia
AU - Shackleford, David M.
AU - Barker, Helena
AU - Ryan, Eileen
AU - Scheurer, Christian
AU - Tang, Yuanqing
AU - Zhao, Qingjie
AU - Zhou, Lin
AU - White, Karen L.
AU - Urwyler, Heinrich
AU - Charman, William N.
AU - Matile, Hugues
AU - Wittlin, Sergio
AU - Charman, Susan A.
AU - Vennerstrom, Jonathan L.
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/4/13
Y1 - 2017/4/13
N2 - Building on insights gained from the discovery of the antimalarial ozonide arterolane (OZ277), we now describe the structure-activity relationship (SAR) of the antimalarial ozonide artefenomel (OZ439). Primary and secondary amino ozonides had higher metabolic stabilities than tertiary amino ozonides, consistent with their higher pKa and lower log D7.4 values. For primary amino ozonides, addition of polar functional groups decreased in vivo antimalarial efficacy. For secondary amino ozonides, additional functional groups had variable effects on metabolic stability and efficacy, but the most effective members of this series also had the highest log D7.4 values. For tertiary amino ozonides, addition of polar functional groups with H-bond donors increased metabolic stability but decreased in vivo antimalarial efficacy. Primary and tertiary amino ozonides with cycloalkyl and heterocycle substructures were superior to their acyclic counterparts. The high curative efficacy of these ozonides was most often associated with high and prolonged plasma exposure, but exposure on its own did not explain the presence or absence of either curative efficacy or in vivo toxicity.
AB - Building on insights gained from the discovery of the antimalarial ozonide arterolane (OZ277), we now describe the structure-activity relationship (SAR) of the antimalarial ozonide artefenomel (OZ439). Primary and secondary amino ozonides had higher metabolic stabilities than tertiary amino ozonides, consistent with their higher pKa and lower log D7.4 values. For primary amino ozonides, addition of polar functional groups decreased in vivo antimalarial efficacy. For secondary amino ozonides, additional functional groups had variable effects on metabolic stability and efficacy, but the most effective members of this series also had the highest log D7.4 values. For tertiary amino ozonides, addition of polar functional groups with H-bond donors increased metabolic stability but decreased in vivo antimalarial efficacy. Primary and tertiary amino ozonides with cycloalkyl and heterocycle substructures were superior to their acyclic counterparts. The high curative efficacy of these ozonides was most often associated with high and prolonged plasma exposure, but exposure on its own did not explain the presence or absence of either curative efficacy or in vivo toxicity.
UR - https://www.scopus.com/pages/publications/85017420633
U2 - 10.1021/acs.jmedchem.6b01586
DO - 10.1021/acs.jmedchem.6b01586
M3 - Article
C2 - 28052200
AN - SCOPUS:85017420633
SN - 0022-2623
VL - 60
SP - 2654
EP - 2668
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 7
ER -